Samsung Engineering Co. Ltd. (028050)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 62,200.00 |
|---|---|
| 52-week range | 23,150.00 – 67,300.00 |
| Return, 1 month / 3 months | +26.0% / +30.5% |
| Return, 1 year / 3 years | +126.3% / +152.1% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 69.1% |
| Worst drawdown (1 year) | -39.1% |
| Average daily value traded | 109,131.35M KRW |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Samsung Engineering is an engineering, procurement and construction company based in Seoul, Korea. It designs and builds industrial plants for clients in the energy and chemicals industries, including oil and gas facilities, refineries, petrochemical complexes and power plants. The company also provides related services such as feasibility studies, project management and plant maintenance. Its customers are mainly energy companies, chemical producers and public utilities that need large process plants built and commissioned.
The shares are listed on the Korea Exchange in Korea under the code 028050, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Samsung Engineering Co. Ltd. (028050) trades on the Korea Exchange in Korea. It last closed at KRW 62,200.00 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 63 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 126.3% and over the last three months it rose 30.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 98 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 43.6% | ||
| From 52-week high | -3.4% | ||
| Momentum | 96 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 30.5% | ||
| 6-month return | 14.5% | ||
| 12-month return, skipping the last month | 79.6% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 69.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.1% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 109,131.35M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 11 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +42.7% |
|---|---|
| 1 month | +26.0% |
| 3 months | +30.5% |
| 6 months | +14.5% |
| 1 year | +126.3% |
| 3 years | +152.1% |
| 5 years | +155.0% |
Signals
| 50-day / 200-day average | 48,843.00 / 43,322.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3,323.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 790.0000 |
| 27 Dec 2024 | KRW 660.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.